---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042867"
form_type: "8-K"
ticker: "FBLG"
cik: "0001958777"
company_name: "FibroBiologics, Inc."
filed_at: "2024-10-29T23:59:59+00:00"
generated_at: "2026-05-30T09:25:27.931416+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# CFO Mark Andersen resigns; Board member Robert Hoffman appointed Interim CFO

## Summary
- Mark Andersen resigns as CFO effective up to Nov 15, 2024; will transition duties.
- Robert Hoffman, current Board member, appointed Interim CFO effective Oct 30, 2024.
- Hoffman receives $45,833/month cash compensation; steps down from Audit/Compensation Committees.
- Richard Cilento becomes Audit Committee Chairman; Stacy Coen joins Audit; Matthew Link leads Compensation Committee.
- Andersen eligible for nine months base salary severance plus COBRA reimbursement on signing release.

## SEC filing metadata
- accession: 0001493152-24-042867
- form_type: 8-K
- ticker: FBLG
- cik: 0001958777
- company_name: FibroBiologics, Inc.
- filed_at: 2024-10-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958777/000149315224042867/0001493152-24-042867-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958777/000149315224042867/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042867
- JSON: https://secwatch.observer/filing/0001493152-24-042867.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042867.txt

## Key facts
- Executive change
  Mark Andersen resigned as Chief Financial Officer at FibroBiologics, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On October 25, 2024, Mr. Mark Andersen informed FibroBiologics, Inc. (the “Company”) of his decision to voluntarily resign from his position as the Company’s Chief Financial Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1958777/000149315224042867/0001493152-24-042867-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
